What does CUSIP 00430K865 represent in this 13F holders report?

CUSIP 00430K865 is the security identifier for ACST - Grace Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held ACST - Grace Therapeutics, Inc. - Common Stock in Q1 2024?

10 institutional investors reported ACST - Grace Therapeutics, Inc. - Common Stock for Q1 2024. Use the holders table for investor-level position and value details.

Grace Therapeutics, Inc. - Common Stock (ACST)

CUSIP: 00430K865

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class: Equity / Common Stock
Total 13F shares: 1,265,432
Total 13F value: $4,337,046
Share change: +694,155
SEC-reported price per share: $3.42
Number of holders: 10
Value change: +$2,382,665
Number of buys: 4
Number of sells: 4
Shares outstanding: 16,612,245

Security key

00430K865

Report period

Q1 2024

Institutions

Top holders

ACST full security history Ownership snapshot Full 13F holder table Grace Therapeutics, Inc. SEC filings Grace Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ACST - Grace Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Rajitha Grace 2018 Irrevo...

Disclosed value leader

BANK OF AMERICA CORP /DE/

Comparable rows

0/15

Latest evidence

31 Dec 2023

3/4/5 13F Highest disclosed value: $1,429,677 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BANK OF AMERICA CORP /DE/ has the largest disclosed position value at $1.43M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BANK OF AMERICA CORP /DE/'s linked filing trail.

Disclosed position value Top 5

BANK OF AMERICA CORP /DE/ $1.43M

ADAR1 Capital Management, LLC $99.8K

ROYAL BANK OF CANADA $92K

UBS Group AG $16.2K

NATIONAL BANK OF CANADA /FI/ $8K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Rajitha Grace 2018 Irrevocable Trust	3/4/5 10%+ Owner 3/4/5	— denominator unverified	— 4,689,547 shares	—	27 Aug 2021
BANK OF AMERICA CORP /DE/	13F Company 13F	— denominator unverified	$1,429,677 494,698 shares	—	31 Dec 2023
ADAR1 Capital Management, LLC	13F Company 13F	— denominator unverified	$99,797 34,532 shares	—	31 Dec 2023
ROYAL BANK OF CANADA	13F Company 13F	— denominator unverified	$92,000 31,584 shares	—	31 Dec 2023
UBS Group AG	13F Company 13F	— denominator unverified	$16,190 5,602 shares	—	31 Dec 2023
NATIONAL BANK OF CANADA /FI/	13F Company 13F	— denominator unverified	$7,970 2,901 shares	—	31 Dec 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,265,432

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q1 2024 value	Value change	Value Chg %